View Financial HealthUbionLtd 配当と自社株買い配当金 基準チェック /16UbionLtd配当を支払う会社であり、現在の利回りは1.79%です。主要情報1.8%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新お知らせ • Apr 14Ubion Co.Ltd. (KOSDAQ:A084440) announces an Equity Buyback for KRW 600 million worth of its shares.Ubion Co.Ltd. (KOSDAQ:A084440) announces a share repurchase program. Under the program, the company will repurchase up to KRW 600 million worth of it's shares. The purpose of the program is to enhance shareholder value and provide performance-based compensation for employees and executives. The program will expire on October 14, 2026. As of April 12, 2026, the company had 580,379 shares in treasury within scope available for dividend and had 0 shares under other acquisitions.お知らせ • Jan 21Ubion Co.Ltd. (KOSDAQ:A084440) announces an Equity Buyback for KRW 600 million worth of its shares.Ubion Co.Ltd. (KOSDAQ:A084440) announces a share repurchase program. Under the program, the company will repurchase up to KRW 600 million worth of it's shares. The purpose of the program is to enhance shareholder value and provide performance-based compensation for employees and executives. The program will expire on July 22, 2026. As of January 20, 2026, the company had 0 shares in treasury within scope available for dividend and had 0 shares under other acquisitions.すべての更新を表示Recent updatesお知らせ • Apr 14Ubion Co.Ltd. (KOSDAQ:A084440) announces an Equity Buyback for KRW 600 million worth of its shares.Ubion Co.Ltd. (KOSDAQ:A084440) announces a share repurchase program. Under the program, the company will repurchase up to KRW 600 million worth of it's shares. The purpose of the program is to enhance shareholder value and provide performance-based compensation for employees and executives. The program will expire on October 14, 2026. As of April 12, 2026, the company had 580,379 shares in treasury within scope available for dividend and had 0 shares under other acquisitions.Reported Earnings • Feb 24First quarter 2026 earnings released: EPS: ₩2.00 (vs ₩70.00 in 1Q 2025)First quarter 2026 results: EPS: ₩2.00 (down from ₩70.00 in 1Q 2025). Revenue: ₩8.14b (down 27% from 1Q 2025). Net income: ₩32.8m (down 98% from 1Q 2025). Profit margin: 0.4% (down from 13% in 1Q 2025). The decrease in margin was driven by lower revenue.New Risk • Feb 24New major risk - Revenue and earnings growthEarnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 15% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩20.6b market cap, or US$14.3m).お知らせ • Jan 21Ubion Co.Ltd. (KOSDAQ:A084440) announces an Equity Buyback for KRW 600 million worth of its shares.Ubion Co.Ltd. (KOSDAQ:A084440) announces a share repurchase program. Under the program, the company will repurchase up to KRW 600 million worth of it's shares. The purpose of the program is to enhance shareholder value and provide performance-based compensation for employees and executives. The program will expire on July 22, 2026. As of January 20, 2026, the company had 0 shares in treasury within scope available for dividend and had 0 shares under other acquisitions.Reported Earnings • Dec 17Full year 2025 earnings released: EPS: ₩68.00 (vs ₩142 loss in FY 2024)Full year 2025 results: EPS: ₩68.00 (up from ₩142 loss in FY 2024). Revenue: ₩33.7b (up 1.2% from FY 2024). Net income: ₩1.34b (up ₩4.14b from FY 2024). Profit margin: 4.0% (up from net loss in FY 2024). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.分析記事 • Aug 22These 4 Measures Indicate That UbionLtd (KOSDAQ:084440) Is Using Debt ExtensivelyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • Feb 20First quarter 2025 earnings released: EPS: ₩70.00 (vs ₩11.00 loss in 1Q 2024)First quarter 2025 results: EPS: ₩70.00 (up from ₩11.00 loss in 1Q 2024). Revenue: ₩11.1b (up 36% from 1Q 2024). Net income: ₩1.39b (up ₩1.61b from 1Q 2024). Profit margin: 13% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue.分析記事 • Dec 18UbionLtd (KOSDAQ:084440) Is Making Moderate Use Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Dec 17Full year 2024 earnings released: ₩142 loss per share (vs ₩28.00 loss in FY 2023)Full year 2024 results: ₩142 loss per share (further deteriorated from ₩28.00 loss in FY 2023). Revenue: ₩33.3b (up 4.6% from FY 2023). Net loss: ₩2.80b (loss widened 414% from FY 2023).お知らせ • Dec 13Ubion Co.Ltd., Annual General Meeting, Dec 27, 2024Ubion Co.Ltd., Annual General Meeting, Dec 27, 2024, at 11:00 Tokyo Standard Time. Location: seminar room, guro-gu, seoul South KoreaNew Risk • Nov 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Revenue has declined by 4.5% over the past year. Minor Risk Market cap is less than US$100m (₩15.1b market cap, or US$10.7m).Reported Earnings • Sep 02Third quarter 2024 earnings released: ₩23.00 loss per share (vs ₩17.00 loss in 3Q 2023)Third quarter 2024 results: ₩23.00 loss per share (further deteriorated from ₩17.00 loss in 3Q 2023). Revenue: ₩9.22b (up 17% from 3Q 2023). Net loss: ₩468.8m (loss widened ₩420.4m from 3Q 2023).Reported Earnings • Mar 06First quarter 2024 earnings released: ₩11.00 loss per share (vs ₩11.09 profit in 1Q 2023)First quarter 2024 results: ₩11.00 loss per share (down from ₩11.09 profit in 1Q 2023). Revenue: ₩8.17b (up 17% from 1Q 2023). Net loss: ₩225.7m (down 221% from profit in 1Q 2023).New Risk • Jun 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (₩38.3b market cap, or US$29.6m).Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Is New 90 Day High Low • Feb 24New 90-day high: ₩5,050The company is up 32% from its price of ₩3,825 on 26 November 2020. The South Korean market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Services industry, which is up 4.0% over the same period.Is New 90 Day High Low • Dec 14New 90-day low: ₩3,150The company is down 6.0% from its price of ₩3,350 on 15 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Services industry, which is up 6.0% over the same period.Is New 90 Day High Low • Oct 28New 90-day high: ₩3,700The company is up 24% from its price of ₩2,990 on 30 July 2020. The South Korean market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Services industry, which is up 3.0% over the same period.Is New 90 Day High Low • Sep 25New 90-day high: ₩3,600The company is up 21% from its price of ₩2,980 on 26 June 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Services industry, which is down 3.0% over the same period.決済の安定と成長配当データの取得安定した配当: A084440の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: A084440の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場UbionLtd 配当利回り対市場A084440 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (A084440)1.8%市場下位25% (KR)1.0%市場トップ25% (KR)3.8%業界平均 (Consumer Services)6.5%アナリスト予想 (A084440) (最長3年)n/a注目すべき配当: A084440の配当金 ( 1.79% ) はKR市場の配当金支払者の下位 25% ( 1.02% ) よりも高くなっています。高配当: A084440の配当金 ( 1.79% ) はKR市場の配当金支払者の上位 25% ( 3.78% ) と比較すると低いです。株主への利益配当収益カバレッジ: A084440の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: A084440が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YKR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 07:07終値2026/05/21 00:00収益2025/12/31年間収益2025/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ubion Co.Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 14Ubion Co.Ltd. (KOSDAQ:A084440) announces an Equity Buyback for KRW 600 million worth of its shares.Ubion Co.Ltd. (KOSDAQ:A084440) announces a share repurchase program. Under the program, the company will repurchase up to KRW 600 million worth of it's shares. The purpose of the program is to enhance shareholder value and provide performance-based compensation for employees and executives. The program will expire on October 14, 2026. As of April 12, 2026, the company had 580,379 shares in treasury within scope available for dividend and had 0 shares under other acquisitions.
お知らせ • Jan 21Ubion Co.Ltd. (KOSDAQ:A084440) announces an Equity Buyback for KRW 600 million worth of its shares.Ubion Co.Ltd. (KOSDAQ:A084440) announces a share repurchase program. Under the program, the company will repurchase up to KRW 600 million worth of it's shares. The purpose of the program is to enhance shareholder value and provide performance-based compensation for employees and executives. The program will expire on July 22, 2026. As of January 20, 2026, the company had 0 shares in treasury within scope available for dividend and had 0 shares under other acquisitions.
お知らせ • Apr 14Ubion Co.Ltd. (KOSDAQ:A084440) announces an Equity Buyback for KRW 600 million worth of its shares.Ubion Co.Ltd. (KOSDAQ:A084440) announces a share repurchase program. Under the program, the company will repurchase up to KRW 600 million worth of it's shares. The purpose of the program is to enhance shareholder value and provide performance-based compensation for employees and executives. The program will expire on October 14, 2026. As of April 12, 2026, the company had 580,379 shares in treasury within scope available for dividend and had 0 shares under other acquisitions.
Reported Earnings • Feb 24First quarter 2026 earnings released: EPS: ₩2.00 (vs ₩70.00 in 1Q 2025)First quarter 2026 results: EPS: ₩2.00 (down from ₩70.00 in 1Q 2025). Revenue: ₩8.14b (down 27% from 1Q 2025). Net income: ₩32.8m (down 98% from 1Q 2025). Profit margin: 0.4% (down from 13% in 1Q 2025). The decrease in margin was driven by lower revenue.
New Risk • Feb 24New major risk - Revenue and earnings growthEarnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 15% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩20.6b market cap, or US$14.3m).
お知らせ • Jan 21Ubion Co.Ltd. (KOSDAQ:A084440) announces an Equity Buyback for KRW 600 million worth of its shares.Ubion Co.Ltd. (KOSDAQ:A084440) announces a share repurchase program. Under the program, the company will repurchase up to KRW 600 million worth of it's shares. The purpose of the program is to enhance shareholder value and provide performance-based compensation for employees and executives. The program will expire on July 22, 2026. As of January 20, 2026, the company had 0 shares in treasury within scope available for dividend and had 0 shares under other acquisitions.
Reported Earnings • Dec 17Full year 2025 earnings released: EPS: ₩68.00 (vs ₩142 loss in FY 2024)Full year 2025 results: EPS: ₩68.00 (up from ₩142 loss in FY 2024). Revenue: ₩33.7b (up 1.2% from FY 2024). Net income: ₩1.34b (up ₩4.14b from FY 2024). Profit margin: 4.0% (up from net loss in FY 2024). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
分析記事 • Aug 22These 4 Measures Indicate That UbionLtd (KOSDAQ:084440) Is Using Debt ExtensivelyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • Feb 20First quarter 2025 earnings released: EPS: ₩70.00 (vs ₩11.00 loss in 1Q 2024)First quarter 2025 results: EPS: ₩70.00 (up from ₩11.00 loss in 1Q 2024). Revenue: ₩11.1b (up 36% from 1Q 2024). Net income: ₩1.39b (up ₩1.61b from 1Q 2024). Profit margin: 13% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue.
分析記事 • Dec 18UbionLtd (KOSDAQ:084440) Is Making Moderate Use Of DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Dec 17Full year 2024 earnings released: ₩142 loss per share (vs ₩28.00 loss in FY 2023)Full year 2024 results: ₩142 loss per share (further deteriorated from ₩28.00 loss in FY 2023). Revenue: ₩33.3b (up 4.6% from FY 2023). Net loss: ₩2.80b (loss widened 414% from FY 2023).
お知らせ • Dec 13Ubion Co.Ltd., Annual General Meeting, Dec 27, 2024Ubion Co.Ltd., Annual General Meeting, Dec 27, 2024, at 11:00 Tokyo Standard Time. Location: seminar room, guro-gu, seoul South Korea
New Risk • Nov 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Revenue has declined by 4.5% over the past year. Minor Risk Market cap is less than US$100m (₩15.1b market cap, or US$10.7m).
Reported Earnings • Sep 02Third quarter 2024 earnings released: ₩23.00 loss per share (vs ₩17.00 loss in 3Q 2023)Third quarter 2024 results: ₩23.00 loss per share (further deteriorated from ₩17.00 loss in 3Q 2023). Revenue: ₩9.22b (up 17% from 3Q 2023). Net loss: ₩468.8m (loss widened ₩420.4m from 3Q 2023).
Reported Earnings • Mar 06First quarter 2024 earnings released: ₩11.00 loss per share (vs ₩11.09 profit in 1Q 2023)First quarter 2024 results: ₩11.00 loss per share (down from ₩11.09 profit in 1Q 2023). Revenue: ₩8.17b (up 17% from 1Q 2023). Net loss: ₩225.7m (down 221% from profit in 1Q 2023).
New Risk • Jun 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Shareholders have been diluted in the past year (32% increase in shares outstanding). Market cap is less than US$100m (₩38.3b market cap, or US$29.6m).
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Is New 90 Day High Low • Feb 24New 90-day high: ₩5,050The company is up 32% from its price of ₩3,825 on 26 November 2020. The South Korean market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Services industry, which is up 4.0% over the same period.
Is New 90 Day High Low • Dec 14New 90-day low: ₩3,150The company is down 6.0% from its price of ₩3,350 on 15 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Services industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Oct 28New 90-day high: ₩3,700The company is up 24% from its price of ₩2,990 on 30 July 2020. The South Korean market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Services industry, which is up 3.0% over the same period.
Is New 90 Day High Low • Sep 25New 90-day high: ₩3,600The company is up 21% from its price of ₩2,980 on 26 June 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Services industry, which is down 3.0% over the same period.